Important Update on Listing Status and Strategic Direction
03. Januar 2024 07:00 ET
|
Nemaura Medical, Inc
Loughborough, UK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs,...
Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth
21. November 2023 08:30 ET
|
Nemaura Medical, Inc
Loughborough, UK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital...
Nemaura Medical Announces Participation at HLTH 2023, Las Vegas
12. September 2023 09:26 ET
|
Nemaura Medical, Inc
LOUGHBOROUGH, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc.(NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercialising non-invasive...
Nemaura Medical Announces SFDA Approval of sugarBEAT®
17. August 2023 08:30 ET
|
Nemaura Medical, Inc
Loughborough, England, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
Nemaura Medical Secures $6.5m in Non-Dilutive Funding
11. August 2023 16:05 ET
|
Nemaura Medical, Inc
Loughborough, England, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on commercializing a daily disposable wearable glucose sensor and...
Nemaura Medical to Participate at the Collision Conference in Toronto June 26-29, 2023
22. Juni 2023 08:00 ET
|
Nemaura Medical, Inc
LOUGHBOROUGH, June 22, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on non-invasive wearable sensors and personalized weight...
Nemaura Medical to Exhibit and Provide Live Product Demonstrations of Its Non-invasive Glucose Sensor at the 83rd Scientific Sessions of the American Diabetes Association June 23-26, 2023
15. Juni 2023 08:00 ET
|
Nemaura Medical, Inc
LOUGHBOROUGH, June 15, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive...
Nemaura Medical to Participate in Fireside Chat Hosted by EF Hutton
21. März 2023 08:00 ET
|
Nemaura Medical, Inc
LOUGHBOROUGH, March 21, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Commences Pilot Program of Miboko with the NHS in the United Kingdom
29. November 2022 08:00 ET
|
Nemaura Medical, Inc
LOUGHBOROUGH, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive...
Nemaura Receives Provisional Purchase Order from Middle East Licensee TPMENA
12. Oktober 2022 11:00 ET
|
Nemaura Medical, Inc
LOUGHBOROUGH, ENGLAND, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and...